OptionsHouse

Options Trading News

January 18, 2013  Fri 7:35 AM CT

MS: SEE CHART GET CHAIN FIND STRATEGIES

Profit Comes in Better Than Expected

Morgan Stanley reported fourth-quarter earnings of $0.28 a share, beating the $0.27 average analyst forecast. Revenue missed expectations, but investors are focusing on that profit number, sending MS up by more than 6 percent before the bell on my tradeMONSTER platform.

FDA Approves Migraine Skin Patch

NuPath announced late yesterday that the Food & Drug Administration approved its Zecuity skin patch for the treatment of migraines, making it the first such product on the market. PATH rallies 19 percent on the news.

Research in Motion Keeps Moving

Research in Motion keeps moving! Today, it was upgraded to "buy" from "hold" at Jefferies, which cited the possibility of its Blackberry mail being able to work on iPhones and Android devices. The target price was raised to $19.50 from $13. RIMM is up 7 percent in the premarket.

Capital One Drops on Earnings Miss

Capital One earned just $1.41 a share in the fourth quarter on revenue of $5.62 billion. Analysts had expected $1.58 and $5.71 billion, respectively. Those results have COF down 7 percent in early trading.

Share this article with your friends


Related Stories

MS

Long-term call sale hits Morgan Stanley

July 11, 2016

A large trade is betting that gains will be limited through early 2018 in the investment bank, which is scheduled to report earnings on July 20.

OptionsHouse

TRADING WEEKLY OPTIONS

The fastest money in the market
View full report »

Premium Services

Education & Strategy

Know thyself before trading

All too often people jump into market without considering some basic guidelines that have as much to do about themselves...

View more education articles »